Drug
Drug a potential noninvasive treatment to remove fat from under neck
An injectable drug currently approved to treat varicose veins is having its safety and efficacy tested in a phase 2b study to evaluate its potential as a treatment option for noninvasive fat removal under the neck.
VIDEO: Drug recognition evaluation overlaps with vision testing
WASHINGTON — Drug recognition evaluations that law enforcement officers perform include components similar to pupil testing and tracking, Harvey Richman, OD, and Maria Richman, OD, said in this Healio video at Optometry’s Meeting.
VIDEO: Common drug interactions clinicians should be aware of
SAN DIEGO — In this video at the ACP Internal Medicine Meeting, Douglas S. Paauw, MD, MACP, discusses recent evidence on drug interactions and other safety indications with common medications.
Targeted drug demonstrates safety, potential to stop cancer growth in early trials
A targeted cancer drug developed by researchers at Norwegian University of Science and Technology and spin-off company APIM Therapeutics has demonstrated positive findings in phase 1 trials, according to a paper published in Oncogene.
European Commission grants second orphan drug designation for TMB-001
The European Commission has granted orphan drug designation for TMB-001 for the treatment of X-linked recessive ichthyosis, Timber Pharmaceuticals announced in a press release.
Avacincaptad pegol new drug application receives priority review
The FDA granted priority review for a new drug application for avacincaptad pegol for the treatment of geographic atrophy secondary to age-related macular degeneration, according to an Iveric Bio press release.
FDA grants orphan drug designation to AI-created drug for idiopathic pulmonary fibrosis
The FDA granted orphan drug designation to INS018_055, an anti-fibrotic small molecule inhibitor, for treating patients with idiopathic pulmonary fibrosis, according to a press release from the drug’s manufacturer.
Incidence of infective endocarditis-related stroke linked to rise in IV drug use
Infective endocarditis-related stroke was increasingly associated with IV drug use and fewer traditional risk factors such as diabetes and hypertension, a trend researchers attributed to recent demographics of the opioid epidemic.
Endocrinology Drug and Device Update
CMS releases final rule for expanded immunosuppressive drug coverage
Patients with a kidney transplant who are younger than 65 years qualify for expanded immunosuppressive drug coverage starting Jan. 1, 2023.